Weight loss: GI Dynamics' EndoBarrier launches in Austria - Mass Device

Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!

September 21, 2011 by MassDevice staff

GI Dynamics launches its EndoBarrier gastrointestinal sleeve in Austria as a treatment for obesity and Type II diabetes.

Obesity and diabetes device maker GI Dynamics (ASX:GID) announced the launch of its EndoBarrier gastrointestinal liner in Austria and the establishment of two "Centers of Excellence" to implant the device.

The Barmherzige Brüder Hospital and the Hallein Clinic are the first centers established in Austria by the Lexington, Mass.-based company, both known for their treatment of metabolic disorders, according to a press release. A hospital is certified as an EndoBarrier center following a training and proctorship program in Type II diabetes and obesity management by GI Dynamics and field experts.

"There is an urgent need for less invasive, yet effective treatments for Type II diabetes and obesity," said Helmut Weiss, head of general surgery at Barmherzige Brüder Hospital in prepared remarks. "The EndoBarrier has the potential to assist many Austrians living with Type II diabetes and obesity control their diabetes and lose weight."

Sign up to get our free newsletters delivered right to your inbox.

GI Dynamics' device is a plastic sleeve inserted endoscopically into the small intestine, where it slows the uptake of nutrients from food to induce weight loss and help control the symptoms of diabetes.

series of clinical studies in 2009 showed that patients treated with the EndoBarrier reduced their average blood glucose levels, lowered other diabetic factors including fasting blood glucose and weight and helped morbidly obese patients lose significant amounts of weight.

The EndoBarrier is currently available in Chile, Europe and more recently in Australia. GI Dynamics received an investigational device exemption approval to commence a pilot trial in the U.S.

GI Dynamics made its début on the Australian Securities exchange earlier this month, opening at $1.07 but falling 13 percent on the first day.

22 Sep, 2011

Source: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEe7dbqEqiylHMnVUawHZlr80JtKQ&url=http://www.massdevice.com/news/weight-loss-gi-dynamics-endobarrier-launches-austria
Manage subscription | Powered by rssforward.com

What's on Your Mind...

Powered by Blogger.